17 Despite awareness of glucocorticoid-associated AEs, Chandran et al showed a trend towards longer glucocorticoid treatment duration over the last decades. 18 In contrast, the Giant-Cell Arteritis Actemra (GiACTA)-trial applied a rapid 26-week glucocorticoid tapering regimen to demonstrate the superiority of tocilizumab over glucocorticoid treatment to prevent relapses.
← all excerpts
Rapid glucocorticoid tapering regimen in patients with giant cell arteritis: a single centre cohort study.
1
—
—